Related Experiment Video
Updated: Oct 17, 2025

06:10
Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice
Published on: September 16, 2020
2.4K
Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice
Verena Fischer1, Deniz Ragipoglu1, Johanna Diedrich1
1Institute of Orthopedic Research and Biomechanics, University Medical Center Ulm, Ulm, Germany.
Summary
Mast cells impair bone fracture healing in estrogen-deficient conditions, like osteoporosis. Targeting mast cells may improve bone repair in postmenopausal women.
Area of Science:
- Immunology
- Endocrinology
- Orthopedics
Background:
- Mast cells are immune cells implicated in osteoporosis.
- Estrogen deficiency, common in postmenopausal women, exacerbates bone loss and may affect fracture healing.
Purpose of the Study:
- To investigate the role of mast cells in impaired fracture healing under estrogen-deficient conditions.
- To elucidate the mechanisms by which mast cells affect bone repair.
Main Methods:
- Utilized mast cell-deficient mice (Mcpt5-Cre R-DTA) in an ovariectomy (OVX) model to assess fracture healing.
- Analyzed inflammatory mediators, immune cell infiltration, osteoblast and osteoclast activity, and serum RANKL levels.
- Conducted in vitro studies with human cells to examine mast cell-mediated osteoclastogenesis.
Main Results:
- Mast cell-deficient mice showed protected fracture healing after OVX.
- Mast cells promoted fracture site inflammation and neutrophil infiltration via mediators like IL-6, Mdk, and CXCL10.
- Mast cells reduced osteoblast activity and increased osteoclast activity and serum RANKL in OVX mice.
- Mast cells stimulated estrogen-dependent osteoclastogenesis via estrogen receptor alpha.
Conclusions:
- Mast cells negatively impact bone fracture healing in estrogen-deficient states.
- Targeting mast cells presents a potential therapeutic strategy for improving bone repair in postmenopausal osteoporosis.
Related Concept Videos
Osteoclasts in Bone Remodeling
3.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.4K
Bone Remodeling
38.8K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.8K
Bone Disorders
4.2K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.2K

